Free Trial
→ Warren Buffett Issues Cryptic Warning on U.S. Dollar (From Banyan Hill Publishing) (Ad)tc pixel Free CPRX Stock Alerts

Catalyst Pharmaceuticals (CPRX) SEC Filings & 10K Form

Catalyst Pharmaceuticals logo
$20.02 -0.05 (-0.25%)
Closing price 04:00 PM Eastern
Extended Trading
$20.10 +0.08 (+0.40%)
As of 05:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

Recent Catalyst Pharmaceuticals SEC Filings

Export to Excel
DateFilerForm TypeView
09/10/2025
4:00 PM		Catalyst Pharmaceuticals (Issuer)
Elsbernd Brian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/05/2025
4:00 PM		Catalyst Pharmaceuticals (Issuer)
Elsbernd Brian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2025
10:28 AM		Catalyst Pharmaceuticals (Subject)
Elsbernd Brian (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/03/2025
11:19 AM		Catalyst Pharmaceuticals (Subject)
Elsbernd Brian (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/28/2025
3:30 PM		Catalyst Pharmaceuticals (Filer)
Form 8-K/A
08/27/2025
3:14 PM		Catalyst Pharmaceuticals (Subject)
Tierney David S (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/26/2025
12:07 PM		Catalyst Pharmaceuticals (Subject)
Miller Steve (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/26/2025
9:46 AM		Catalyst Pharmaceuticals (Subject)
Daly Richard J (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/25/2025
3:30 PM		Catalyst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/08/2025
4:00 PM		Catalyst Pharmaceuticals (Issuer)
Curran Daniel J. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/04/2025
3:31 PM		Catalyst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/06/2025
2:42 PM		Catalyst Pharmaceuticals (Subject)
MCENANY PATRICK J (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/02/2025
1:44 PM		Catalyst Pharmaceuticals (Subject)
O'Keeffe Charles B (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/14/2025
9:45 AM		Catalyst Pharmaceuticals (Subject)
INGENITO GARY (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/13/2025
10:14 AM		Catalyst Pharmaceuticals (Subject)
INGENITO GARY (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/28/2025
11:32 AM		BlackRock, Inc. (Filed by)
Catalyst Pharmaceuticals (Subject)
Form SCHEDULE 13G/A
04/14/2025
4:19 PM		Catalyst Pharmaceuticals (Filer)
Form ARS
04/09/2025
7:55 AM		Catalyst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/07/2025
4:00 PM		Catalyst Pharmaceuticals (Issuer)
INGENITO GARY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2025
3:09 PM		Catalyst Pharmaceuticals (Subject)
INGENITO GARY (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/03/2025
3:21 PM		Catalyst Pharmaceuticals (Subject)
Elsbernd Brian (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/03/2025
9:21 AM		Catalyst Pharmaceuticals (Subject)
Del Carmen Jeffrey (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/28/2025
4:40 PM		Catalyst Pharmaceuticals (Issuer)
Russo Gregg (Reporting)
Form 3/A
02/26/2025
3:37 PM		Catalyst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/26/2025
3:05 PM		Catalyst Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/13/2025
7:57 AM		Catalyst Pharmaceuticals (Subject)
Flynn James E (Filed by)
Form SCHEDULE 13G/A
01/24/2025
3:30 PM		Catalyst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/21/2025
3:30 PM		Catalyst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/13/2025
5:07 AM		Catalyst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/31/2024
3:30 PM		Catalyst Pharmaceuticals (Issuer)
Harper Molly (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/31/2024
3:30 PM		Catalyst Pharmaceuticals (Issuer)
Sundaram Preethi (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/31/2024
3:30 PM		Catalyst Pharmaceuticals (Issuer)
Del Carmen Jeffrey (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/31/2024
3:30 PM		Catalyst Pharmaceuticals (Issuer)
DENKHAUS DONALD A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/31/2024
3:30 PM		Catalyst Pharmaceuticals (Issuer)
Elsbernd Brian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/31/2024
3:30 PM		Catalyst Pharmaceuticals (Issuer)
Daly Richard J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/31/2024
3:30 PM		Catalyst Pharmaceuticals (Issuer)
INGENITO GARY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/31/2024
3:30 PM		Catalyst Pharmaceuticals (Issuer)
Tierney David S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/31/2024
3:30 PM		Catalyst Pharmaceuticals (Issuer)
O'Keeffe Charles B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/31/2024
3:30 PM		Catalyst Pharmaceuticals (Issuer)
Miller Steve (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/17/2024
4:24 PM		Catalyst Pharmaceuticals (Issuer)
Miller Steve (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2024
4:00 PM		Catalyst Pharmaceuticals (Issuer)
Del Carmen Jeffrey (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2024
4:00 PM		Catalyst Pharmaceuticals (Issuer)
Sundaram Preethi (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2024
4:00 PM		Catalyst Pharmaceuticals (Issuer)
DENKHAUS DONALD A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2024
4:00 PM		Catalyst Pharmaceuticals (Issuer)
O'Keeffe Charles B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2024
4:00 PM		Catalyst Pharmaceuticals (Issuer)
MCENANY PATRICK J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2024
4:00 PM		Catalyst Pharmaceuticals (Issuer)
Harper Molly (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2024
4:00 PM		Catalyst Pharmaceuticals (Issuer)
Elsbernd Brian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2024
4:00 PM		Catalyst Pharmaceuticals (Issuer)
Tierney David S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2024
4:00 PM		Catalyst Pharmaceuticals (Issuer)
INGENITO GARY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2024
4:00 PM		Catalyst Pharmaceuticals (Issuer)
Thompson Tamar (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2024
4:00 PM		Catalyst Pharmaceuticals (Issuer)
Miller Steve (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/10/2024
11:55 AM		Catalyst Pharmaceuticals (Subject)
Miller Steve (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/29/2024
7:08 PM		Catalyst Pharmaceuticals (Issuer)
Elsbernd Brian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/29/2024
7:09 PM		Catalyst Pharmaceuticals (Issuer)
Harper Molly (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/29/2024
7:09 PM		Catalyst Pharmaceuticals (Issuer)
INGENITO GARY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/27/2024
1:42 PM		Catalyst Pharmaceuticals (Subject)
INGENITO GARY (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/27/2024
8:42 AM		Catalyst Pharmaceuticals (Subject)
Harper Molly (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/26/2024
11:37 AM		Catalyst Pharmaceuticals (Subject)
Elsbernd Brian (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/25/2024
4:00 PM		Catalyst Pharmaceuticals (Issuer)
Elsbernd Brian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/25/2024
4:00 PM		Catalyst Pharmaceuticals (Issuer)
Thompson Tamar (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/25/2024
4:00 PM		Catalyst Pharmaceuticals (Issuer)
Daly Richard J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/25/2024
4:00 PM		Catalyst Pharmaceuticals (Issuer)
Harper Molly (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/25/2024
4:01 PM		Catalyst Pharmaceuticals (Issuer)
O'Keeffe Charles B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/25/2024
4:01 PM		Catalyst Pharmaceuticals (Issuer)
Kalb Michael Wayne (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/25/2024
4:01 PM		Catalyst Pharmaceuticals (Issuer)
INGENITO GARY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/25/2024
4:01 PM		Catalyst Pharmaceuticals (Issuer)
Tierney David S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/25/2024
4:01 PM		Catalyst Pharmaceuticals (Issuer)
DENKHAUS DONALD A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/25/2024
4:01 PM		Catalyst Pharmaceuticals (Issuer)
Miller Steve (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/25/2024
4:01 PM		Catalyst Pharmaceuticals (Issuer)
MCENANY PATRICK J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/25/2024
4:01 PM		Catalyst Pharmaceuticals (Issuer)
Sundaram Preethi (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/25/2024
4:01 PM		Catalyst Pharmaceuticals (Issuer)
Del Carmen Jeffrey (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/22/2024
4:00 PM		Catalyst Pharmaceuticals (Issuer)
INGENITO GARY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/21/2024
4:11 PM		Catalyst Pharmaceuticals (Issuer)
MCENANY PATRICK J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/20/2024
1:57 PM		Catalyst Pharmaceuticals (Subject)
MCENANY PATRICK J (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/15/2024
4:00 PM		Catalyst Pharmaceuticals (Issuer)
MCENANY PATRICK J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/14/2024
8:55 AM		Catalyst Pharmaceuticals (Subject)
Flynn James E (Filed by)
Form SC 13G/A
11/13/2024
4:44 PM		Catalyst Pharmaceuticals (Issuer)
MCENANY PATRICK J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/12/2024
9:52 AM		Catalyst Pharmaceuticals (Subject)
MCENANY PATRICK J (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/06/2024
4:10 PM		Catalyst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/06/2024
3:08 PM		Catalyst Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/18/2024
2:31 PM		BlackRock, Inc. (Filed by)
Catalyst Pharmaceuticals (Subject)
Form SC 13G/A
10/17/2024
11:14 AM		Catalyst Pharmaceuticals (Subject)
STATE STREET CORP (Filed by)
Form SC 13G/A
09/26/2024
7:42 AM		Catalyst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:CPRX) was last updated on 9/17/2025 by MarketBeat.com Staff
From Our Partners
He Called Nvidia at $1.10. Now, He Says THIS Stock Will…
The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...
The Oxford Club | Sponsoredtc pixel
INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
Right now, we’re witnessing a monumental shift in the world.
Traders Agency | Sponsoredtc pixel
Strange crypto pattern discovered by 40-person research team
Something unusual is happening inside a 40-person crypto research firm. They're helping 8,000+ ordinary peo...
Crypto Swap Profits | Sponsoredtc pixel
Why Trump’s “Smart Dollar” could rewrite the rules
MUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...
Stansberry Research | Sponsoredtc pixel
“Fed Proof” Your Bank Account with THESE 4 Simple Steps
Starting as soon as a few months from now, the United States government will make a sweeping change to bank ac...
Weiss Ratings | Sponsoredtc pixel
Forget AI Stocks — This Device Will REPLACE the Microchip
While everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...
Banyan Hill Publishing | Sponsoredtc pixel
IRS Wants Another Check on Sept 15th—What If You Could Keep It Instead?
On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...
American Alternative | Sponsoredtc pixel
Forget NVDA. Put $1,000 into this stock now
A massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...
Chaikin Analytics | Sponsoredtc pixel